MJ-26

• Target :

  Epigenetic Reader Domain

• Related Pathways :

  Chromatin/Epigenetic

• Bioactivity :

  MJ-26 is an inhibitor targeting Menin, characterized by a high binding affinity (Ki: 0.56 ?M) and significant antiproliferative activity. It functions by inhibiting Menin-MLL interaction and promoting the degradation of Menin protein. MJ-26 demonstrates notable antitumor effects against acute myeloid leukemia (AML) and is applicable for AML research.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C